Assignee
CARDURION PHARMACEUTICALS INC
US·6 granted patents·4 pending applications·2 citations·filing 2020–2024
Top patents by PatentIndex Score
10 records- 0183US12006319B2Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-oneCARDURION PHARMACEUTICALS INC·Filed 2020·Granted Jun 11, 2024·2 cites·20 claims
- 0271US12528816B2Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitorsCARDURION PHARMACEUTICALS INC·Filed 2023·Granted Jan 20, 2026·0 cites·24 claims
- 0371US2025120974A1Pde9 inhibitors for treating sickle cell diseaseCARDURION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0470US2025019381A1PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL)-3-(TETRAHYDROPYRAN-4-YL-7H-IMIDAZO[1,5-a]PYRAZIN-8-ONECARDURION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0568US12466832B2Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-oneCARDURION PHARMACEUTICALS INC·Filed 2024·Granted Nov 11, 2025·0 cites·11 claims
- 0667US11999741B2Process for the synthesis of 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-3-(tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-oneCARDURION PHARMACEUTICALS INC·Filed 2022·Granted Jun 4, 2024·0 cites·11 claims
- 0767US2025145630A1Polymorphs of a pyridinylimidazo[1,2-b]pyridazineCARDURION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0863US12213975B2PDE9 inhibitors for treating sickle cell diseaseCARDURION PHARMACEUTICALS INC·Filed 2021·Granted Feb 4, 2025·0 cites·7 claims
- 0963US11795172B2Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitorsCARDURION PHARMACEUTICALS INC·Filed 2021·Granted Oct 24, 2023·0 cites·15 claims
- 1055US2024025904A1Pde9 inhibitors for treating cardiac failureCARDURION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →